Which one of the following Indian institutes was approved by the Drugs

Which one of the following Indian institutes was approved by the Drugs Controller General of India for conducting human trials of the Oxford-AstraZeneca Covid-19 vaccine candidate?

Bharat Biotech
AIIMS
Serum Institute of India
National Institute of Epidemiology
This question was previously asked in
UPSC CDS-2 – 2020
The Serum Institute of India (SII), based in Pune, was approved by the Drugs Controller General of India (DCGI) to conduct phase 2 and 3 human clinical trials in India for the Oxford-AstraZeneca COVID-19 vaccine candidate, known as Covishield. SII had a partnership with AstraZeneca for the manufacturing and supply of the vaccine in India and globally.
– The question specifically asks about the Indian institute approved for *conducting human trials* of the Oxford-AstraZeneca vaccine candidate.
– Serum Institute of India was the primary partner in India for the manufacturing and trials of this specific vaccine.
Bharat Biotech developed its own indigenous COVID-19 vaccine, Covaxin. AIIMS (All India Institute of Medical Sciences) and other institutions are involved in clinical trials of various vaccines but Serum Institute of India was the lead partner for the Oxford-AstraZeneca vaccine trials in India. The National Institute of Epidemiology is primarily involved in epidemiological research.
Exit mobile version